Siriraj Hospital

Siriraj Piyamaharajkarun Hospital in Thailand has incorporated AI and computational technologies into its recently launched pathology information system. WHAT IT'S ABOUT The PIS at the 300-bed SiPH, a hospital unit under the Faculty of Medicine of Siriraj Hospital, integrates laboratory workflows, imaging scanning systems, and centralised data processing. Previously, SiPH, which opened in 2012, did not have its own pathology laboratory. "[We] instead sent samples to the Pathology Department at Siriraj Hospital," shared Dr Pornsuk Cheunsuchon, director of SiPH's Digital Pathology Center. In planning this system in late 2021, AI was a major consideration. The PIS, which went live earlier in March, features speech-to-text and smart forms to simplify data entry. Another AI, powered by IBM processing technology, analyses high-resolution slide images, streamlining the identification of potential cancerous tissues – this AI is currently applied to suspected prostate cancer cases. The PIS is also powered by IBM's data storage and security solutions. WHY IT MATTERS "Speed and accuracy of work have increased," Dr Cheunsuchon told Healthcare IT News when asked about the AI implementation. The PIS, he noted, "introduced significant automation to various aspects of workflow," including documentation and identification of high-risk cases. The system can also automatically order additional tests and provide alerts for major findings. "For example, speech-to-text technology has reduced typing errors, while AI assists in prostate cancer case screening by helping pathologists prioritise preliminary results," Dr Cheunsuchon said. "The system enables automatic ordering of additional tests and filters cases to provide alerts for significant findings, thereby reducing manual workload and streamlining the overall diagnostic process," he added. SiPH's AI-driven pathology service has now served over 14,000 test orders. The hospital continues to upgrade and enhance the system, including user interface and experience. SiPH plans to further expand "integrated, automated AI-powered diagnostics" to accurately detect more cancer cases. THE LARGER TREND In digital pathology, another Asian hospital, Samsung Medical Center from South Korea, might have the most comprehensive system in the world thus far. Last year, it became the first hospital in the world to reach Stage 7 of the HIMSS Digital Imaging Adoption Model . Among the features of its integrated digital pathology system is 5G network connectivity , which reportedly helped greatly reduce test consultation times.

Korea opens access to cancer data of 2 million patients Researchers in South Korea can now access an expanded big-data repository on 2.26 million cancer patients. The Korean Ministry of Health and Welfare (MOHW), together with the National Cancer Center and the Korea Health Information Service, has recently announced the addition of more data to the K-CURE Public Cancer Library. According to a press release, access to K-CURE data, which includes anonymised data on registered cancer patients, insurance eligibility and claims, and mortality, has been expanded to cover data from 2012 to 2020. Additionally, the dataset on COVID-19 infection and vaccination from the Korea Disease Control and Prevention Agency has been added to the public data library. After securing the necessary permits, researchers can access public cancer data through designated data utilisation centres . Korea launches $25M AI drug discovery project The MOHW has also recently announced that it started a joint project with the Ministry of Science and ICT to discover and develop new drugs using AI technology. In a statement, the ministry said the 34.8 billion won ($25 million) project will build an AI-driven ADME/T prediction model to discover new drug candidates. This will be developed through an AI training platform based on federated learning, a machine learning technique that taps into data from multiple, decentralised sources without exchanging or moving them. The project, run by the Korea Pharmaceutical and Bio-Pharma Manufacturers Association, has chosen 20 participating organisations, including pharmaceutical companies and universities, to enhance and verify the resulting AI model. Thailand's Siriraj Hospital deploys AI for lymphoma diagnosis The Faculty of Medicine at Siriraj Hospital of Mahidol University has recently deployed AI to support the diagnosis of lymphoma. Based on a press statement, the hospital started utilising an object detection algorithm to spot and count centroblast cells in Hematoxylin and Eosin-stained whole slide images. "This development is significant for lymphoma grading, facilitating more precise patient classification into stages 1, 2, or 3 based on the progress of the disease," it explained. Siriraj Hospital has been deploying AI across its departments since 2018. By year-end, it plans to introduce AI to analyse mammograms and CT brain scans.

KISSIMMEE, Fla., March 26, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Rumpa Amornmarn, MD is acknowledged as a Pinnacle Lifetime Member for her contributions to the Radiation Oncology industry. Dr. Amornmarn, a highly respected and board-certified specialist in cancer treatment, stands as a dedicated advocate for her patients' well-being. With an unwavering commitment to saving lives and helping patients regain their everyday activities, she has earned a distinguished reputation in the medical field. Continue Reading Rumpa Amornmarn Dr. Amornmarn specializes in the treatment of cancer patients, with a particular focus on breast and prostate cancers. As the President of her private practice, she leads by example, supervising all medical staff, managing financial aspects, and ensuring optimal division performance. Her exceptional leadership and expertise drive her practice's success. Dr. Amornmarn's expertise extends to intensity-modulated radiation therapy, a cutting-edge approach that offers precise and effective cancer treatment. Her commitment to staying at the forefront of medical advancements ensures her patients receive the best care possible. Dr. Amornmarn maintains affiliations with esteemed organizations, including the American Society of Therapeutic Radiology and Oncology, the American College of Radiology, The Radiologic Society, the American Society of Clinical Oncology, Johns Hopkins Medical and Surgical Society, and the Johns Hopkins Medical Alumni Association. These affiliations reflect her dedication to professional development and knowledge sharing within the medical community. Dr. Amornmarn's journey in medicine began with pre-medical studies at Chulalongkorn University in Bangkok, Thailand. She earned her MD degree from Siriraj Medical School/Mahidol University in Thailand and further honed her skills through residencies in internal medicine at the Veterans Affairs Hospital in Washington, DC, as well as therapeutic radiology and a fellowship in radiology and oncology, both completed at Johns Hopkins University. Her board certification in radiology underscores her expertise. Dr. Amornmarn's commitment to advancing cancer treatment is evident in her contributions to the field. She has authored numerous presentations and contributed more than 25 articles to professional journals, further solidifying her position as a thought leader in her domain. Dr. Amornmarn's unwavering dedication to her patients remains her driving force. She envisions continuing her vital work while continually seeking improvements in medical care to better serve her patients. Dr. Amornmarn honors her parents, Che Penty, and Mecho Mai, in her pursuit of excellence. In her personal life, she has been married to Mr. Surachai Sutha for 43 years, and they have one son. Dr. Amornmarn's impressive career spanning over four decades is a testament to her passion for cancer treatment and her commitment to making a meaningful difference in the lives of her patients. Contact: Katherine Green, 516-825-5634, [email protected] SOURCE The Inner Circle